Our Policy Manager responds to the UK Government's decision to delay the social care costs cap.

Today (26 July), the European Union’s drugs regulator, the Committee for Medicinal Products for Human Use (CHMP), has advised that the drug lecanemab, a treatment for Alzheimer’s disease, should not be approved for use in the EU.

New figures from the NHS show that record numbers of people are being diagnosed with dementia in England.

A survey by Alzheimer’s Society reveals 88% of people affected by dementia have not contacted a dementia charity for support.

The Football Association (FA) and Alzheimer’s Society have today announced a further extension to its charity partnership until July 2025. 

Our Director of Research responds to news that the FDA has approved new Alzheimer's disease drug donanemab in the US.

UK dementia organisations have joined forces to publish a new dementia manifesto ahead of the General Election on 4 July 2024.

Alzheimer’s Society is calling on the Government to make dementia a priority and urgently fix diagnosis as just 1.4% of dementia healthcare costs are spent on diagnosis and treatment, with families shouldering 63% of the costs.

A new book about The Beatles, which has been designed specifically with, and for, people with dementia, is released today (Monday 15 April), with the accompanying audio voiced by actor Bill Nighy.

Two world-class research teams will carry out countrywide trials to identify accurate and quick blood tests that can diagnose dementia, in a bid to improve the UK’s shocking diagnosis rate.

Last night, the third dedicated Alzheimer’s Society International took place, with the England’s men’s team once again wearing nameless shirts as part of powerful stunt.